BCR-ABL1-Negative Chronic Myeloproliferative Neoplasms and Pulmonary Hypertension: A Prospective Long-Term Follow-up Study of the Impact of Pulmonary Hypertension on Survival

Payzin, Kadriye; Savasoglu, Kaan; ALACACIOĞLU, İNCİ; Dalgic, Elif; Kucukzeybek, Betul; Calli, Aylin; Bener, Sadi; PAYZIN, SERDAR

doi:10.1016/j.clml.2020.08.006

BCR-ABL1-Negative Chronic Myeloproliferative Neoplasms and Pulmonary Hypertension: A Prospective Long-Term Follow-up Study of the Impact of Pulmonary Hypertension on Survival

Atıf İçin Kopyala

Payzin K. B., Savasoglu K., ALACACIOĞLU İ., Dalgic E. E., Kucukzeybek B. B., Calli A. O., ...Daha Fazla

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, cilt.21, sa.2, ss.125-131, 2021 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 21 Sayı: 2
Basım Tarihi: 2021
Doi Numarası: 10.1016/j.clml.2020.08.006
Dergi Adı: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
Sayfa Sayıları: ss.125-131
Anahtar Kelimeler: Essential thrombocythemia, JAK2 mutation, Polycythemia vera, Primary myelofibrosis, Pulmonary hypertension, ARTERIAL-HYPERTENSION, DIAGNOSIS, MYELOFIBROSIS, SECONDARY
Dokuz Eylül Üniversitesi Adresli: Evet

Özet

This prospective study assessed the prevalence of pulmonary hypertension (PHT) related to chronic myeloproliferative neoplasms (CMPNs) and evaluated the impact of PHT on survival during long-term follow-up. In a large group of BCR-ABL1-negative CMPN patients, there was a low prevalence of PHT. The impact of PHT on survival was negligible.